Neurogene Inc. is a clinical-stage biotechnology company developing genetic medicines for rare neurological diseases. Its proprietary EXACT (Expression Attenuation via Construct Tuning) technology uses microRNA-based genetic circuits to regulate transgene expression. Its lead program, NGN-401, is in a registrational trial (Embolden) for Rett syndrome, delivered via one-time intracerebroventricular AAV injection. The company operates its own cGMP manufacturing facility in Houston, Texas.
expected 2026-11-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-24 | 2025-12-31 | 0001404644-26-000019 | EDGAR | 103K words |
| 2025-03-24 | 2024-12-31 | 0001404644-25-000012 | EDGAR | 106K words |
| 2024-03-18 | 2023-12-31 | 0001404644-24-000020 | EDGAR | 100K words |
| 2023-03-20 | 2022-12-31 | 0001628280-23-008602 | EDGAR | 69K words |
| 2022-03-01 | 2021-12-31 | 0001628280-22-004491 | EDGAR | 66K words |
| 2021-03-25 | 2020-12-31 | 0001628280-21-005630 | EDGAR | 63K words |
| 2020-03-12 | 2019-12-31 | 0001193125-20-071545 | EDGAR | 69K words |
| 2019-03-07 | 2018-12-31 | 0001193125-19-066506 | EDGAR | 64K words |
| 2018-03-12 | 2017-12-31 | 0001193125-18-079210 | EDGAR | 69K words |
| 2017-03-09 | 2016-12-31 | 0001193125-17-076939 | EDGAR | 72K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-11 | 2026-06-30 | 0001404644-26-000059 | EDGAR | 64K words |
| 2025-11-13 | 2025-09-30 | 0001404644-25-000101 | EDGAR | 64K words |
| 2025-08-11 | 2025-06-30 | 0001404644-25-000081 | EDGAR | 63K words |
| 2025-05-09 | 2025-03-31 | 0001404644-25-000041 | EDGAR | 59K words |
| 2024-11-18 | 2024-09-30 | 0001404644-24-000104 | EDGAR | 60K words |
| 2024-08-09 | 2024-06-30 | 0001404644-24-000086 | EDGAR | 58K words |
| 2024-05-10 | 2024-03-31 | 0001404644-24-000057 | EDGAR | 52K words |
| 2023-11-14 | 2023-09-30 | 0001628280-23-038797 | EDGAR | 54K words |
| 2023-08-10 | 2023-06-30 | 0001628280-23-028856 | EDGAR | 53K words |
| 2023-05-08 | 2023-03-31 | 0001628280-23-016425 | EDGAR | 48K words |
| 2022-11-14 | 2022-09-30 | 0001628280-22-029833 | EDGAR | 48K words |
| 2022-08-09 | 2022-06-30 | 0001628280-22-021923 | EDGAR | 46K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-11 | 0001404644-26-000056 | EDGAR | 2K words |
| 2026-03-24 | 0001404644-26-000012 | EDGAR | 4K words |
| 2026-02-26 | 0001404644-26-000006 | EDGAR | 1K words |
| 2026-01-12 | 0001404644-26-000003 | EDGAR | 4K words |
| 2025-11-13 | 0001404644-25-000103 | EDGAR | 2K words |
| 2025-11-12 | 0001404644-25-000098 | EDGAR | 3K words |
| 2025-11-06 | 0001404644-25-000091 | EDGAR | 5K words |
| 2025-10-09 | 0001404644-25-000088 | EDGAR | 5K words |
| 2025-08-11 | 0001404644-25-000082 | EDGAR | 2K words |
| 2025-06-30 | 0001404644-25-000070 | EDGAR | 5K words |
229 total filings indexed. 197 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001404644 |
| Ticker | NGNE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Headquarters | Houston, Texas |
| Website | https://www.neurogene.com |
| Listed | 2023-12-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/NGNE (~200 tokens, structured JSON with cryptographic provenance)